4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-24-019370
Chief Operating Officer bought 24,000 shares at an average $0.77 ($18,480)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cittadine Andrew Chief Operating Officer | 2024-06-03 | Purchase | +12,000 | $0.76 | $9,120 | 105,624 | D |
| Cittadine Andrew Chief Operating Officer | 2024-06-04 | Purchase | +12,000 | $0.78 | $9,360 | 117,624 | D |
| Open-market purchases · 24,000 sh · avg $0.77 · $18,480 | |||||||
Loading xslF345X05/rdgdoc.xml…